Fixes Record Date for Interim Dividend
Aventis Pharma Ltd has informed BSE that July 27, 2010 has been fixed as the Record Date for the purpose of payment of Interim Dividend for year ending December 31, 2010.15-07-2010
15-07-2010
Board to consider Interim Dividend
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 19, 2010, for:1. Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2010; and2. Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2010.08-07-2010
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Aventis Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:18-06-2010
Outcome of AGM
Aventis Pharma Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on April 27, 2010, inter alia, have accorded to the following:1. Adoption of the Accounts for the year ended December 31, 2009 being the Balance Sheet as at December 31, 2009 and the Profit and Loss Account for the year ended on that date with the Auditors Report and the Report of the Directors....02-06-2010
Financial Results for Mar 31, 2010
Aventis Pharma Ltd has informed BSE about the Financial Results for the Quarter ended March 31, 2010.27-04-2010
Disclosures under Reg. 7(1) & 7(1A) of SEBI (SAST) Regulations, 1997
United Breweries (Holdings) Ltd has submitted the disclosure under Regulation 7(1) & 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE17-04-2010
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Aventis Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE17-04-2010
Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Aventis Pharma Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE17-04-2010
Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997
Aventis Pharma Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE14-04-2010
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Aventis Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE14-04-2010